-
1 Comment
Doctorglasses Chain Co.,Ltd is currently in a long term uptrend where the price is trading 25.0% above its 200 day moving average.
From a valuation standpoint, the stock is 8.9% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 5.6.
Doctorglasses Chain Co.,Ltd's total revenue rose by 3.4% to $186M since the same quarter in the previous year.
Its net income has increased by 27.8% to $21M since the same quarter in the previous year.
Finally, its free cash flow grew by 68.4% to $47M since the same quarter in the previous year.
Based on the above factors, Doctorglasses Chain Co.,Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002PH4 |
| Sector | Consumer Cyclical |
| Industry | Specialty Retail |
| Beta | -0.14 |
|---|---|
| Target Price | None |
| Market Cap | 7B |
| PE Ratio | 68.56 |
| Dividend Yield | 2.0% |
Doctorglasses Chain Co.,Ltd. engages in the retail of eyewear in China. It offers optical glasses; fitting services for frames and lenses; finished mirror glasses, including sunglasses, reading glasses, etc.; contact lenses; hard contact lenses; care solutions, and eye health peripheral products. The company provides optometry, wearing and debugging, and after-sales services. It sells its products through its store brands comprising doctor glasses, President Optical, Boojing, zèle, Concrete, and ZORRO, as well as through e-commerce and franchise channels. Doctorglasses Chain Co.,Ltd. was founded in 1993 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300622.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
